The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2022 Summer Meeting | Intensity modulated radiotherapy (IMRT) for locally advanced lung cancer
John Conibear, MBBCh, BSc, MSc, MRCP, FRCR, St Barts Health NHST, UK, discusses the use of intensity modulated radiotherapy (IMRT) for the treatment of locally advanced lung cancer. IMRT has been demonstrated to allow for the treatment of larger lung cancers than other treatment modalities, increasing the rate of curative treatment for locally advanced lung cancer. This interview took place at the BTOG 2022 Summer Meeting congress in London.
